Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
BMC Public Health|March 24, 2011
Explaining variation in the uptake of HPV vaccination in EnglandVarun M Kumar, David K Whynes
Journal of Managed Care & Specialty Pharmacy|May 29, 2019
A Summary from the Institute for Clinical and Economic Review's New England Comparative Effectiveness Public Advisory CouncilIfeoma S Otuonye, Reiner Banken, Varun M Kumar, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 13, 2021
Does Cost-Effectiveness Analysis Overvalue Potential Cures? Exploring Alternative Methods for Applying a "Shared Savings" Approach to Cost OffsetsRichard H Chapman, Varun M Kumar, Melanie D Whittington, et al.
Cost Effectiveness and Resource Allocation : C/E|October 12, 2020
Cost effectiveness of nusinersen for patients with infantile-onset spinal muscular atrophy in USPraveen Thokala, Matt Stevenson, Varun M Kumar, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 13, 2019
Impact of Abuse Deterrent Formulations of Opioids in Patients With Chronic Pain in the United States: A Cost-Effectiveness ModelVarun M Kumar, Foluso Agboola, Patricia G Synnott, et al.
Pharmacotherapy|March 31, 2018
Cost-Effectiveness Analysis of Sacubitril/Valsartan for the Treatment of Heart Failure with Reduced Ejection Fraction in the United StatesPatrick M Zueger, Varun M Kumar, Rachel L Harrington, et al.
Journal of Managed Care & Specialty Pharmacy|December 28, 2018
Assessing the Value of Sarilumab Monotherapy for Adults with Moderately to Severely Active Rheumatoid Arthritis: A Cost-Effectiveness AnalysisMelanie D Whittington, R Brett McQueen, Daniel A Ollendorf, et al.
JAMA Pediatrics|October 11, 2018
Long-term Survival and Value of Chimeric Antigen Receptor T-Cell Therapy for Pediatric Patients With Relapsed or Refractory LeukemiaMelanie D Whittington, R Brett McQueen, Daniel A Ollendorf, et al.
JAMA Network Open|February 23, 2019
Long-term Survival and Cost-effectiveness Associated With Axicabtagene Ciloleucel vs Chemotherapy for Treatment of B-Cell LymphomaMelanie D Whittington, R Brett McQueen, Daniel A Ollendorf, et al.
Journal of Managed Care & Specialty Pharmacy|May 1, 2019
The Effectiveness and Value of Biologic Therapies for the Treatment of Uncontrolled AsthmaJeffrey A Tice, Jonathan D Campbell, Patricia G Synnott, et al.
Pageof 2